Johnston SR - Search Results

1

Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.

Martin LA, Farmer I, Johnston SR, Ali S, Dowsett M. Martin LA, et al. Among authors: johnston sr. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S75-84. doi: 10.1677/erc.1.01023. Endocr Relat Cancer. 2005. PMID: 16113101

2

Towards a molecular basis for tamoxifen resistance in breast cancer.

Johnston SR, Dowsett M, Smith IE. Johnston SR, et al. Ann Oncol. 1992 Jul;3(7):503-11. doi: 10.1093/oxfordjournals.annonc.a058251. Ann Oncol. 1992. PMID: 1498070 Free article. Review.

3

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M. Johnston SR, et al. Cancer Res. 1995 Aug 1;55(15):3331-8. Cancer Res. 1995. PMID: 7614468

4

Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.

Daffada AA, Johnston SR, Smith IE, Detre S, King N, Dowsett M. Daffada AA, et al. Among authors: johnston sr. Cancer Res. 1995 Jan 15;55(2):288-93. Cancer Res. 1995. PMID: 7812959

5

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen.

Johnston SR, MacLennan KA, Sacks NP, Salter J, Smith IE, Dowsett M. Johnston SR, et al. Eur J Cancer. 1994;30A(11):1663-9. doi: 10.1016/0959-8049(94)00327-2. Eur J Cancer. 1994. PMID: 7833141

6

Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancer.

Dowsett M, Johnston SR, Iveson TJ, Smith IE. Dowsett M, et al. Among authors: johnston sr. Lancet. 1995 Feb 25;345(8948):525. doi: 10.1016/s0140-6736(95)90624-x. Lancet. 1995. PMID: 7861903 Clinical Trial. No abstract available.

7

Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction.

Daffada AA, Johnston SR, Nicholls J, Dowsett M. Daffada AA, et al. Among authors: johnston sr. J Mol Endocrinol. 1994 Dec;13(3):265-73. doi: 10.1677/jme.0.0130265. J Mol Endocrinol. 1994. PMID: 7893344

8

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

Johnston SR, Haynes BP, Smith IE, Jarman M, Sacks NP, Ebbs SR, Dowsett M. Johnston SR, et al. Lancet. 1993 Dec 18-25;342(8886-8887):1521-2. doi: 10.1016/s0140-6736(05)80088-1. Lancet. 1993. PMID: 7902904

9

Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer.

Johnston SR, Smith IE, Doody D, Jacobs S, Robertshaw H, Dowsett M. Johnston SR, et al. Cancer Res. 1994 Nov 15;54(22):5875-81. Cancer Res. 1994. PMID: 7954417 Clinical Trial.

10

Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.

Saccani Jotti G, Johnston SR, Salter J, Detre S, Dowsett M. Saccani Jotti G, et al. Among authors: johnston sr. J Clin Pathol. 1994 Oct;47(10):900-5. doi: 10.1136/jcp.47.10.900. J Clin Pathol. 1994. PMID: 7962603 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters